BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 3624827)

  • 1. Depression and dexamethasone suppression testing in children and adolescents.
    Emslie GJ; Weinberg WA; Rush AJ; Weissenburger J; Parkin-Feigenbaum L
    J Child Neurol; 1987 Jan; 2(1):31-7. PubMed ID: 3624827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone suppression test in psychiatric patients with psychoactive substance dependence.
    Olivera AA; Fero D; Scibilia J
    Am J Drug Alcohol Abuse; 1991 Sep; 17(3):295-305. PubMed ID: 1928023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the dexamethasone suppression test with DSM-III criteria in psychiatrically hospitalized adolescents.
    Evans DL; Nemeroff CB; Haggerty JJ; Pedersen CA
    Psychoneuroendocrinology; 1987; 12(3):203-9. PubMed ID: 3615749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four definitions of endogenous depression and the dexamethasone suppression test.
    Zimmerman M; Coryell W; Pfohl B; Stangl D
    J Affect Disord; 1985; 8(1):37-45. PubMed ID: 3156910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dexamethasone suppression test in patients with mood disorders.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Parker CR; Weissenburger JE; Crowley GT; Khatami M; Vasavada N
    J Clin Psychiatry; 1996 Oct; 57(10):470-84. PubMed ID: 8909334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone suppression test results in delusional versus nondelusional depression: preliminary evidence of distinct clinical entities.
    Kraus RP; Remick RA
    J Clin Psychiatry; 1985 May; 46(5):188-90. PubMed ID: 3988719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dexamethasone suppression test in the clinical setting.
    Evans DL; Burnett GB; Nemeroff CB
    Am J Psychiatry; 1983 May; 140(5):586-9. PubMed ID: 6342422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of concurrent medical illness on dexamethasone suppression test results in depressed inpatients.
    Cooke RG; Warsh JJ; Stancer HC; Hasey GM; Jorna T; Langlet F
    Can J Psychiatry; 1990 Feb; 35(1):31-5. PubMed ID: 2317731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary report on the dexamethasone suppression test for psychiatrically disturbed adolescents.
    Crumley FE; Clevenger J; Steinfink D; Oldham D
    Am J Psychiatry; 1982 Aug; 139(8):1062-4. PubMed ID: 7091435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone suppression test response in major depression: stability across hospitalizations.
    Coryell W; Schlesser MA
    Psychiatry Res; 1983 Mar; 8(3):179-89. PubMed ID: 6574537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone suppression test and Axis I diagnoses of inpatients with DSM-III borderline personality disorder.
    Baxter L; Edell W; Gerner R; Fairbanks L; Gwirtsman H
    J Clin Psychiatry; 1984 Apr; 45(4):150-3. PubMed ID: 6715286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dexamethasone on plasma prolactin and cortisol levels in psychiatric patients.
    Meltzer HY; Fang VS; Tricou BJ; Robertson A; Piyaka SK
    Am J Psychiatry; 1982 Jun; 139(6):763-8. PubMed ID: 7081489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary data on the dexamethasone suppression test in children with major depressive disorder.
    Geller B; Rogol AD; Knitter EF
    Am J Psychiatry; 1983 May; 140(5):620-2. PubMed ID: 6846596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dexamethasone suppression test, poststroke depression, and the validity of DSM-III-based diagnostic criteria.
    Ross ED; Gordon WA; Hibbard M; Egelko S
    Am J Psychiatry; 1986 Sep; 143(9):1200-1. PubMed ID: 3752314
    [No Abstract]   [Full Text] [Related]  

  • 15. The dexamethasone suppression test and quantitative cerebral anatomy in depression.
    Coffey CE; Wilkinson WE; Weiner RD; Ritchie JC; Aque M
    Biol Psychiatry; 1993 Mar; 33(6):442-9. PubMed ID: 8490071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interepisode consistency of dexamethasone suppression test results in affective disorders.
    Brizer DA; Brown RP; Kocsis JH; Stokes PE
    Am J Psychiatry; 1986 Apr; 143(4):539-41. PubMed ID: 3953899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dexamethasone suppression test in psychotic disorders.
    Arana GW; Barreira PJ; Cohen BM; Lipinski JF; Fogelson D
    Am J Psychiatry; 1983 Nov; 140(11):1521-3. PubMed ID: 6625007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major depression in the elderly: DSM-III criteria and the dexamethasone suppression test as predictors of treatment response.
    Spar JE; La Rue A
    Am J Psychiatry; 1983 Jul; 140(7):844-7. PubMed ID: 6859297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia.
    Addington D; Addington J
    Can J Psychiatry; 1990 Jun; 35(5):430-3. PubMed ID: 2372754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenocortical function and depressive illness in mentally retarded patients.
    Ruedrich SL; Wadle CV; Sallach HS; Hahn RK; Menolascino FJ
    Am J Psychiatry; 1987 May; 144(5):597-602. PubMed ID: 3578569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.